| Fiscal Year End | Company Status | Exempt Flag |
| February 28 | Suspend | N |
|
|
|
|
|
| Incorporation Locations |
| Inc. Date | Expiry Date | Country | Region | Description |
| 3/Nov/2006 | | Canada | British Columbia | |
|
|
| Exchange Filing Office |
| Location |
| Vancouver Regional Service Office |
|
|  |
| Business Type(s) |
| Primary/Secondary | Business Type | Details |
| Primary
| Research and Development
| Company Website September 5, 2014 - biOasis Technologies Inc. (TSX-V:BTI) is a publically traded biopharmaceutical company focused on developing and commercializing proprietary pharmaceutical products and diagnostic technologies for central nervous system ("CNS") diseases and disorders. Of particular interest is the creation of therapeutic options for patient management to address the limitations to biodistribution presented by the properties of the blood-brain barrier ("BBB").
|
|
|
| Securities |
| Symbol | Security Name | Market | Status |
| BTI | Bioasis Technologies Inc. | TSX Venture | SUSPEND |
|
|
| Name History | From | To |
| Bioasis Technologies Inc. | 3/Apr/2008 | Present |
|
|
| Company Facts Reconciliation |
| Subject | Date Returned |
| Spring 2015 CFR | Not Received |
|
|
|
|
|
